Grants for Public and State controlled institutions of higher education - Federal

This grant provides funding to public health organizations and healthcare providers in the United States to improve prevention, diagnosis, and management of parasitic infections, particularly focusing on Chagas disease, soil-transmitted helminths, and other significant domestic parasitic diseases.

This funding opportunity supports alumni of U.S. government-sponsored exchange programs in Ethiopia to implement community-driven projects that promote sustainable development and foster collaboration.

This program provides funding to support tree planting and urban forestry projects in disadvantaged communities across Georgia, promoting long-term environmental benefits.

It is the policy of my Administration to advance womens health research, close health disparities, and ensure that the gains we make in research laboratories are translated into real-world clinical benefits for women. It is also the policy of my Administration to ensure that women have access to high-quality, evidence-based health care and to improve health outcomes for women across their lifespans and throughout the country. President Joseph R. Biden, Jr., Executive Order 14120 on Advancing Womens Health Research and Innovation, 18 March 2024.In support of the Presidents Executive Order to advance womens health research, the PRORP is releasing this WHRA funding opportunity. The intent of the FY24 PRORP WHRA is to support research focused on orthopaedic issues faced by women serving in military settings, such as infantry and other physically demanding roles, who have sustained orthopaedic injuries. The overall goal of the WHRA is to address factors that contribute to the health and retention of women in military service. Although use of military populations, datasets, or samples are not required, the application should demonstrate how the proposed research relates to issues faced by women serving in military settings. The proposed research project should also include a well-formulated, testable hypothesis based on sound scientific rationale and logical reasoning.Although the PRORP is interested in supporting military-focused research, research supported by the PRORP is expected to also apply to all individuals who have sustained a major orthopaedic injury.The PRORP encourages applications from a spectrum of research areas, including but not limited to translational and clinical research. The PRORP also welcomes qualitative research, population science, and health care services research specifically designed to understand the impact of orthopaedic injuries on female Service Members.With the initiation of the Arthritis Research Program, the FY24 PRORP may not fund arthritis research; however, research that addresses conditions or health abnormalities related to arthritis is permitted provided the proposed research addresses the PRORP WHRAs focus on orthopaedic injuries in women.A key feature of the PRORP WHRA is the relevance to female military and/or Veteran populations following orthopaedic injury. Inclusion of female military and/or Veteran populations is highly encouraged for applications proposing clinical research. Applicants proposing clinical studies in non-military and/or non-Veteran populations must justify the relevance of the proposed research to the military and/or Veteran communities. All applicants should clearly describe how their study design, including recruitment strategies and access to appropriate populations, as applicable, will enable them to meet this intent.Research involving human subjects, human datasets, and human anatomical substances is permitted; however, the WHRA may not be used to conduct clinical trials. Applicants seeking support for a clinical trial should consider the FY24 PRORP Clinical Trial Award (Funding Opportunity Number HT942524PRORPCTA).Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Rigor of Experimental Design: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. Projects that include research on animal models are required to submit Attachment 7, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE guidelines 2.0 (Animal Research: Reporting In Vivo Experiments) to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines 2.0 can be found at https://arriveguidelines.org/arrive-guidelines.Encouraged Department of Defense (DOD) and/or VA Collaboration: Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the VA, and other federal government agencies are encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated total costs budgeted for the entire period of performance for an FY24 PRORP WHRA should not exceed $1.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $3.0M to fund approximately two WHRA applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

This funding opportunity provides financial support to organizations working to empower LGBTQI+ communities globally by enhancing safety, advocating for legal reforms, and promoting social inclusion.

This grant provides funding to Historically Black Colleges and Universities to create or expand educational programs that engage K-12 and community college students in clean energy topics during summer or academic breaks.

This funding opportunity supports projects that preserve historic resources, such as surveys and restorations, benefiting the public and requiring matching funds from the grantee.

This funding opportunity supports U.S. colleges and universities in hiring new tenure-track faculty in geospace science to enhance research, education, and workforce development in solar and space physics and related fields.

This grant provides funding for public and private partnerships to protect and restore wetland habitats in the U.S., benefiting waterfowl and migratory birds through collaborative conservation efforts.

This funding opportunity supports research and development of sustainable bio-based chemicals and renewable propane, targeting collaboration among universities, businesses, and government entities to promote clean energy and economic growth in rural communities.

This funding opportunity is designed for academic or institutional partners within the Colorado Plateau CESU network to conduct research on riparian restoration in the Colorado River Basin, focusing on improving ecological health and supporting avian populations.

The Office of Family Violence Prevention and Services program (OFVPS) Discretionary Grant Program under the Family Violence Prevention and Services Act (FVPSA): Specialized Services for Abused Parents and Their Children (Demonstration Projects) will support fifty (50) demonstration projects. These projects will focus on expanding the capacity (of coalitions, local programs, and community-based programs) to prevent future family violence, domestic violence, and dating violence by appropriately addressing the needs of children exposed to domestic violence, and the potentially co-occurring impacts of child abuse and neglect.

This funding opportunity provides financial support for research projects that explore how policies on tobacco, alcohol, and cannabis use affect health disparities in underserved communities, with a focus on cancer prevention and community collaboration.

This grant provides funding for U.S. educational institutions and organizations to support short-term projects that promote less commonly taught foreign languages and area studies through international seminars, curriculum development, or research abroad.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country. This FOA can support training for conducting research in a broad range of HIV research areas across HIV prevention, treatment, care, and quality of life continuum. This includes basic, epidemiologic, clinical, behavioral and social sciences, community-based, implementation, operations, health services, and health systems research. Cross-disciplinary research as well as HIV associated comorbidities and coinfections affecting the HIV epidemic will be supported under this FOA. An application should focus the proposed training program to strengthen research capacity in a defined high priority HIV scientific area aligned with NIH HIV/AIDS research priorities (NOT-OD-20-018) at a specific LMIC institution and collaborating LMIC partner institutions.

This funding opportunity provides financial support to a variety of organizations to improve coordinated care and research for individuals affected by a rare genetic disorder that causes abnormal blood vessel formation.

This funding opportunity supports small-scale research projects at undergraduate-focused institutions to enhance research capabilities and engage students in biomedical research.

This grant provides funding to researchers and organizations developing innovative medical solutions to improve the treatment and outcomes of burn injuries for military personnel in challenging environments.

The U.S. Embassy Tokyo of the U.S. Department of State announces an open competition for organizations to submit applications to carry out a program for a media study tour for Japanese journalists on trilateral security cooperation. Following the historic August 2023 Trilateral Leaders’ Summit hosted by President Biden at Camp David, the United States, Japan, and Republic of Korea inaugurated “a new era of trilateral partnership,” and committed to strengthening trilateral security cooperation through enhanced trilateral defense exercises, improved information sharing, and increased cooperation on ballistic missile defense, including against DPRK missile threats. To better understand how the trilateral relationship is making strides, print journalists based across Japan will learn firsthand through a five-day media study tour on trilateral security cooperation with travel to Tokyo and Seoul (including the DMZ). They will engage with policymakers and experts from all three nations to gain a deeper understanding of how this enhanced cooperation is occurring and the significance that it plays to the region. The Japan-based journalists will also have an opportunity to meet and network with ROK journalist counterparts, forging important regional connections and facilitating networking connections among media professionals. The U.S. Embassy Tokyo invites proposals from eligible institutions to execute this program. Ground rules for meetings during the trip will be a combination of on-the-record, off-the-record, and background/Chatham House Rule. As much as possible, participating journalists will be encouraged to write articles for their readers around Japan. Proposals should include all cost associated with the program, including: - round-trip international airfare between Japan and the Republic of Korea - domestic travel expenses in Japan (round-trip transportation costs to/from the airport(s) for international departure) - ground transportation and gratuities in the Republic of Korea (e.g., chartered bus) - lodging in the Republic of Korea - ROK visa fee if necessary - overseas travel insurance - meals and incidentals - interpretation fees